News

MDV cooperates with SBI Securities to launch dAIbet, an AI-based mobile application providing lifestyle advice based on health data to prevent diabetes complications

  • July 12, 2022

Medical Data Vision Co., Ltd. (President: Hiroyuki Iwasaki, hereinafter MDV), which owns the largest medical database in Japan, and SBI SECURITIES Co., Ltd. (President and CEO Masato Takamura, hereafter SBI SECURITIES), which has the largest number of securities accounts in Japan with approximately 8.45 million accounts (*) are pleased to announce their new cooperation project to promote diabetes prevention.

(*) The number of SBI accounts includes the number of SBI Neomobile Securities accounts since the end of April 2019, the number of SBI Neotrade Securities accounts since the end of October 2020, and the number of FOLIO accounts since the end of August 2021.

MDV develops and provides the diabetes AI application “dAlbet” (reading “dibet”, coined by combining AI and diabetes). With “dAlbet”, any diabetic patient can enter their vital data such as blood test values to manage their exposure to the risk of diabetes aggravation, by displaying indicators on the screen, which can be useful for health management. Diabetes risk is calculated by AI (artificial intelligence) algorithm based on medical data of MDV. “DAlbet” also provides life-improving measures for diabetes prevention, and users can evaluate how the current risks could be reduced by changing behaviors as a result of implementing those improvement measures. This app is available for free.

MDV and SBI Holdings Co., Ltd. (President: Yoshitaka Kitao), which owns SBI SECURITIES, signed a capital and business alliance in November 2020. Through the cooperation between MDV and SBI SECURITIES, securities account users will receive notifications such as email newsletters. SBI SECURITIES account users will be encouraged to actively work on diabetes prevention by downloading “dAlbet”.

How to use “dAlbet”

  • Download “dAlbet” and start running the application after doing the user registration.
  • Touch the link button with SBI SECURITIES on the profile screen of “dAlbet”.
  • If you do not have an SBI account, go to the account opening guide.
  • If you have an SBI account, input the required information to link your account.
  • When the cooperation is completed, you can check your own financial asset information managed by SBI SECURITIES from “dAlbet”.

Click here to download “dAlbet”

  • Download “dAlbet” and start running the application after doing the user registration.
  • Touch the link button with SBI SECURITIES on the profile screen of “dAlbet”.
  • If you do not have an SBI account, go to the account opening guide.
  • If you have an SBI account, input the required information to link your account.
  • When the cooperation is completed, you can check your own financial asset information managed by SBI SECURITIES from “dAlbet”.
  • Click here to download “dAlbet”

Diabetes is a disease in which the concentration of glucose in the blood (blood sugar level) increases. As the disease worsens, arteriosclerosis progresses, making it more likely to have a stroke or ischemic heart disease. According to the “2019 National Health and Nutrition Survey” (*) conducted by the Ministry of Health, Labor and Welfare, the percentage of “those who are strongly suspected of having diabetes” is 19.7% for men and 10.8% for women. There was a tendency for the proportion to increase.
(*)https://www.mhlw.go.jp/content/10900000/000687163.pdf

<Contact>
Medical Data Vision Co., Ltd.
MAIL: ebm_sales@mdv.co.jp

News

News List
Company website[Japanese] MDV EBM insight[Japanese/English]
© Medical Data Vision Co., Ltd. All Rights Reserved.
© Medical Data Vision Co., Ltd. All Rights Reserved.